Studies have shown that individuals with the ALDH2*2 variant not only have a higher risk for alcohol-related cancer and complications but are also more prone to diabetes-related cardiovascular diseases, including CAD and myocardial infarction, due to the cumulative effects of aldehyde toxicity and metabolic stress. This evidence concerns the gene ALDH2 and coronary artery disorder.